Top Core and Group Health Stories
Trump seeks to lower drug costs for U.S. employers to match European prices
By Allison BellThe move could cut the cost of existing brand-name drugs but hurt the supply of new drugs.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
The move could cut the cost of existing brand-name drugs but hurt the supply of new drugs.